Notably, TCGA-based analyses confirmed that expression of FOLH1 mRNA—which encodes PSMA—in tumor-associated blood vessels holds prognostic significance at the transcriptional level, supporting the potential use of PSMA-targeted imaging in RCC [38]. This evidence concerns the gene FOLH1 and neoplasm.